← Back to Search

Monoclonal Antibodies

A Study to Test if TEV-53275 is Effective in Relieving Asthma

Phase 2
Waitlist Available
Research Sponsored by Teva Branded Pharmaceutical Products R&D, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weeks 12 and 16

Summary

This trial tests a new injection called TEV-53275 for adults with a specific type of asthma that doesn't respond well to usual treatments. The medication works by lowering certain white blood cells to help improve breathing and reduce symptoms.

Eligible Conditions
  • Asthma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weeks 12 and 16
This trial's timeline: 3 weeks for screening, Varies for treatment, and weeks 12 and 16 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change From Baseline in Clinic-based Standardized Baseline-adjusted Morning Trough (Pre-bronchodilator) FEV1 at Week 12
Secondary study objectives
Change From Baseline in Asthma Control Questionnaire (ACQ-6) Score at Weeks 12 and 16
Change From Baseline in Asthma Control Test (ACT) Score at Weeks 12 and 16
Change From Baseline in Clinic-based Standardized Baseline-adjusted Morning Trough (Pre-bronchodilator) FEV1 at Week 16
+20 more

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: TEV-53275 Dose BExperimental Treatment1 Intervention
Group II: TEV-53275 Dose AExperimental Treatment1 Intervention
Group III: PlaceboPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Teva Branded Pharmaceutical Products R&D, Inc.Lead Sponsor
256 Previous Clinical Trials
3,486,317 Total Patients Enrolled
64 Trials studying Asthma
2,616,846 Patients Enrolled for Asthma
Teva Medical Expert, MDStudy DirectorTeva Branded Pharmaceutical Products R&D, Inc.
97 Previous Clinical Trials
39,530 Total Patients Enrolled
23 Trials studying Asthma
13,275 Patients Enrolled for Asthma
~21 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top